A study from I. Maupin and Bryan C. McCannon of West Virginia University found that college admissions counselors discriminate against students based on their gender identity.
Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
A study published in the Journal of Exposure Science and Environmental Epidemiology found that women with higher levels of forever chemicals had a greater risk of developing breast, ovary, skin, and uterus cancer.
